United States S 2817: End Price Gouging for Insulin Act

Status: Introduced in Senate (as of 2019-11-07)

State: United States · Session: 116 · Bill: S 2817

Subjects: Asia, Australia, Canada, Department of Health and Human Services, Europe, Executive agency funding and structure, France, Germany, Health care costs and insurance, Health programs administration and funding, Indian social and development programs, Inflation and prices, Italy, Japan, Medicaid, Medical research, Medicare, Netherlands, North America, Prescription drugs, Research administration and funding, Research and development, Retail and wholesale trades, Spain, Sweden, Switzerland, United Kingdom, Veterans' medical care

Sponsors: Jeff Merkley, RICHARD J. DURBIN

View United States S 2817 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.